• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL Back to Search Results
Model Number 1011487-12
Device Problems Difficult to Remove (1528); Improper or Incorrect Procedure or Method (2017); Failure to Advance (2524); Device Dislodged or Dislocated (2923)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 07/28/2021
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device will not be returned for evaluation, the device was reportedly discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a moderately calcified right renal artery that is 90% stenosed.The 4.0x12mm herculink balloon expandable stent system (bess) was attempted to be advanced; however, failed to cross due to anatomy.The bess was removed and an unspecified 2.0x15mm coronary balloon was used to dilate the lesion.The same bess was re-inserted but failed to cross due to anatomy.During removal, due to the angle of the unspecified guide catheter the bess met resistance with it and the stent dislodged.Several attempts were made to retrieve the floating stent by inserting an unspecified balloon in the stent and partially deploy it in an attempt to snare the stent with the balloon; however, the stent got caught with an unspecified wire and the tip of the unspecified wire separated.Both the tip of the wire and the stent were free floating in the right common femoral artery.The patient was put under anesthesia and a cut down was performed.The stent and tip of the unknown wire were successfully removed, and the patient is doing well.Additionally, the event did cause the patient's hospitalization to be prolonged and a clinically significant delay was noted.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other complaints reported from this lot.Based on the information provided, the reported difficulties resulting in surgical procedure to remove the separated portion of guide wire and the dislodged stent appear to be due to circumstances of the procedure.The difficulty encountered during advancement was due to interaction with the challenging anatomy.Additionally, it was reported that after the first failed attempt to advance, the balloon expandable stent system (bess) was removed for additional dilation of the lesion, then re-advanced in which the bess failed to cross for a second time.It is likely that during the second failed attempt to cross the lesion, the stent became compromised or loose on the balloon resulting in dislodgement during removal when the stent interacted with the guide catheter.The delay in the procedure and prolonged hospitalization were due to case circumstances.It should be noted that the herculink elite instruction for use states: ¿do not attempt to pull an unexpanded stent back through the introducer sheath / guiding catheter; dislodgment of the stent from the balloon may occur.¿ in this case, it could not be determined if re-insertion of the herculink caused or contributed to the stent dislodgement.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX HERCULINK ELITE STENT SYSTEM
Type of Device
STENT, RENAL
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key12320184
MDR Text Key266564765
Report Number2024168-2021-07148
Device Sequence Number1
Product Code NIN
UDI-Device Identifier08717648077821
UDI-Public08717648077821
Combination Product (y/n)N
PMA/PMN Number
P110001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 09/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2023
Device Model Number1011487-12
Device Catalogue Number1011487-12
Device Lot Number0031861
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/29/2021
Initial Date FDA Received08/13/2021
Supplement Dates Manufacturer Received08/27/2021
Supplement Dates FDA Received09/20/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age90 YR
Patient Weight63
-
-